Industrializing engineered autologous T cells as medicines for solid tumours

MLA

Britten, Cedrik M., et al. “Industrializing Engineered Autologous T Cells as Medicines for Solid Tumours.” Nature Reviews Drug Discovery, no. Preprints, Jan. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41573-021-00175-8.

APA

Britten, C. M., Shalabi, A., & Hoos, A. (2024). Industrializing engineered autologous T cells as medicines for solid tumours. Nature Reviews Drug Discovery, Preprints, 1–13. https://doi.org/10.1038/s41573-021-00175-8

Chicago

Britten, Cedrik M., Aiman Shalabi, and Axel Hoos. 2024. “Industrializing Engineered Autologous T Cells as Medicines for Solid Tumours.” Nature Reviews Drug Discovery, no. Preprints (January): 1–13. doi:10.1038/s41573-021-00175-8.